Welcome to our dedicated page for Bath & Body Works news (Ticker: BBWI), a resource for investors and traders seeking the latest updates and insights on Bath & Body Works stock.
Bath & Body Works, Inc. reports developments as a specialty personal care and home fragrance retailer with products spanning fine fragrance mist, body lotion and cream, 3-wick candles, home fragrance diffusers and liquid hand soap. Company updates commonly cover quarterly results and guidance, regular dividends, product launches, seasonal fragrance collections and collaborations across body care, home fragrance, décor and accessories.
Recurring news also addresses the Consumer First Formula strategy, including brand modernization, product innovation, marketplace expansion and the authorized Bath & Body Works storefront in Amazon’s U.S. stores. The company operates retail locations in the U.S. and Canada, uses an online storefront and supports international franchised locations.
Bath & Body Works announced the addition of Alessandro Bogliolo and Juan Rajlin to its Board of Directors, enhancing its strategic leadership.
Bogliolo brings over 30 years of retail experience, previously serving as CEO at Tiffany & Co., while Rajlin is the treasurer of Alphabet Inc., overseeing substantial investments and corporate finance strategies. Both leaders will join the board in May 2022, alongside the departure of Andrew Meslow and Robert Schottenstein. The board will then consist of nine directors, emphasizing diversity with over half from diverse communities. Sarah Nash expressed optimism about leveraging their global experience to drive growth.
Andrew Meslow will resign as CEO of Bath & Body Works on May 12, 2022 for health reasons. Sarah E. Nash has been appointed as Executive Chair and will serve as Interim CEO post-Meslow's departure. The Board of Directors intends to engage a search firm for a permanent CEO. Meslow expressed pride in the company's achievements, including the successful spin-off of Victoria's Secret. Nash acknowledged Meslow's leadership and highlighted the company's record performance in fiscal 2021.
Bath & Body Works (NYSE: BBWI) reported strong financial results for Q4 and full-year 2021. Q4 net sales reached $3.027 billion, an 11% increase year-over-year, with earnings per share of $2.27, up from $1.96 in Q4 2020. For the full year, net sales rose 22% to $7.882 billion, with EPS from continuing operations at $3.94, compared to $3.07 in 2020. The Board authorized a new $1.5 billion share repurchase program and increased the dividend by 33%. For 2022, EPS guidance ranges between $4.30 and $4.70.
Bath & Body Works invites investors to its fourth quarter 2021 earnings conference call scheduled for Feb. 24, 2022, at 9:00 a.m. ET. This call will follow the release of the company's earnings report on Feb. 23. Interested parties can listen via the company’s website or call in using provided numbers. The release emphasizes the company’s commitment to transparency and investor engagement.
Bath & Body Works (NYSE: BBWI) announced a new $1.5 billion share repurchase program and a 33% increase in the annual dividend to $0.80 per share. For the fourth quarter ending January 29, 2022, the company reported net sales of $3.027 billion, up 11% year-over-year. Estimated earnings per share (EPS) from continuing operations are projected at approximately $2.25, exceeding prior guidance. The company maintains a strong balance sheet with approximately $2 billion in cash, positioning itself for sustainable growth.
bBath & Body WorksEPS to be at the high end of $2.10 to $2.25, compared to $1.96 in 2020. The company anticipates a mid- to high-single digit percent increase in sales compared to the prior year. CEO Andrew Meslow expressed satisfaction with the holiday performance, attributing it to strong customer response and execution. The official earnings report is scheduled for February 23, 2022.
Bath & Body Works (BBWI) reported third quarter 2021 earnings with net sales of $1.681 billion, a slight decline from $1.702 billion in Q3 2020 but a 53% increase compared to $1.099 billion in Q3 2019. Earnings per share (EPS) from continuing operations were $0.66, down from $0.69 year-over-year. However, adjusted EPS rose to $0.92 from $0.83 last year. The company forecasts Q4 2021 EPS between $2.10 and $2.25, up from $1.96 in 2020. CEO Andrew Meslow attributed growth to strong customer response and loyal customer base.
Bath & Body Works (NYSE: BBWI) has declared a quarterly dividend of $0.15 per share, payable on Dec. 3, 2021, to shareholders of record by Nov. 19, 2021. This announcement reflects the company's commitment to return value to its investors. Bath & Body Works continues to be a leading specialty retailer, offering a wide range of fragrances for body and home, available at over 1,750 locations in the U.S. and Canada.
Bath & Body Works (NYSE: BBWI) will announce its third quarter 2021 earnings on November 17, after market close. A live webcast of the earnings conference call is scheduled for November 18 at 9:00 a.m. ET, featuring executives from the company. For additional details, participants can log onto the company's website or call designated numbers for domestic and international attendees.
The company continues to lead in specialty retailing with a focus on exclusive fragrances, operating over 1,750 locations in the U.S. and Canada.
Bath & Body Works (NYSE: BBWI) announced the acceptance of $450.1 million in Notes for early settlement as part of its previously announced Tender Offers to buy back outstanding debt, including the 2023, 2025, and 2027 Senior Notes. The Tender Offers are limited to a maximum aggregate amount of $500 million and are subject to proration due to a Sub-Cap of $180 million for the 2025 and 2027 Notes. Purchase payments for accepted notes will be made on September 3, 2021, with tender offers expiring on September 16, 2021.